434 related articles for article (PubMed ID: 1588436)
1. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors.
Arnoldus EP; Wolters LB; Voormolen JH; van Duinen SG; Raap AK; van der Ploeg M; Peters AC
J Neurosurg; 1992 Jun; 76(6):997-1003. PubMed ID: 1588436
[TBL] [Abstract][Full Text] [Related]
2. Interphase cytogenetics of brain tumors.
Arnoldus EP; Noordermeer IA; Peters AC; Voormolen JH; Bots GT; Raap AK; van der Ploeg M
Genes Chromosomes Cancer; 1991 Mar; 3(2):101-7. PubMed ID: 1648958
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
[TBL] [Abstract][Full Text] [Related]
4. Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas.
Rosso SM; van Dekken H; Krishnadath KK; Alers JC; Kros JM
J Neuropathol Exp Neurol; 1997 Oct; 56(10):1125-31. PubMed ID: 9329456
[TBL] [Abstract][Full Text] [Related]
5. Cytogenical analysis of brain tumors by FISH (fluorescence in situ hybridization) and FCM (flow cytometry).
Kasai H; Kawamoto K
Noshuyo Byori; 1995 Mar; 12(1):75-82. PubMed ID: 7795734
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal characteristics of childhood brain tumors.
Bigner SH; McLendon RE; Fuchs H; McKeever PE; Friedman HS
Cancer Genet Cytogenet; 1997 Sep; 97(2):125-34. PubMed ID: 9283596
[TBL] [Abstract][Full Text] [Related]
7. [Cytogenetic study of intracranial tumors].
Rey JA; Bello MJ; Campos JM; Boixados JR; Sánchez Cascos A
Rev Esp Oncol; 1983; 30(4):469-75. PubMed ID: 6599911
[TBL] [Abstract][Full Text] [Related]
8. Karyotypes in 90 human gliomas.
Thiel G; Losanowa T; Kintzel D; Nisch G; Martin H; Vorpahl K; Witkowski R
Cancer Genet Cytogenet; 1992 Feb; 58(2):109-20. PubMed ID: 1551072
[TBL] [Abstract][Full Text] [Related]
9. [Chromosome anomalies in brain tumors].
Berthéas MF; Frappaz D; Elian J; Brizard C; Brunon J; Freycon F
Pediatrie; 1991; 46(1):65-9. PubMed ID: 1851285
[TBL] [Abstract][Full Text] [Related]
10. Incidence of numerical chromosome aberrations in meningioma tumors as revealed by fluorescence in situ hybridization using 10 chromosome-specific probes.
Sayagués JM; Tabernero MD; Maillo A; Díaz P; Rasillo A; Bortoluci A; Gomez-Moreta J; Santos-Briz A; Morales F; Orfao A
Cytometry; 2002 Jun; 50(3):153-9. PubMed ID: 12116338
[TBL] [Abstract][Full Text] [Related]
11. Genomic aberrations in diffuse low-grade gliomas.
Dahlback HS; Gorunova L; Brandal P; Scheie D; Helseth E; Meling TR; Heim S
Genes Chromosomes Cancer; 2011 Jun; 50(6):409-20. PubMed ID: 21412929
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetics of pediatric central nervous system tumors.
Sainati L; Bolcato S; Montaldi A; Celli P; Stella M; Leszl A; Silvestro L; Perilongo G; Cordero di Montezemolo L; Basso G
Cancer Genet Cytogenet; 1996 Oct; 91(1):13-27. PubMed ID: 8908162
[TBL] [Abstract][Full Text] [Related]
13. Chromosome number and carmustine sensitivity in human gliomas.
Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
[TBL] [Abstract][Full Text] [Related]
14. Numerical aberrations of chromosomes 1, 2, and 7 in astrocytomas studied by interphase cytogenetics.
Wernicke C; Thiel G; Lozanova T; Vogel S; Witkowski R
Genes Chromosomes Cancer; 1997 May; 19(1):6-13. PubMed ID: 9135989
[TBL] [Abstract][Full Text] [Related]
15. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses.
Schröck E; Thiel G; Lozanova T; du Manoir S; Meffert MC; Jauch A; Speicher MR; Nürnberg P; Vogel S; Jänisch W
Am J Pathol; 1994 Jun; 144(6):1203-18. PubMed ID: 8203461
[TBL] [Abstract][Full Text] [Related]
16. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
17. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior.
Appley AJ; Fitzgibbons PL; Chandrasoma PT; Hinton DR; Apuzzo ML
Neurosurgery; 1990 Jul; 27(1):83-96. PubMed ID: 2377285
[TBL] [Abstract][Full Text] [Related]
18. DNA content and chromosomal composition of malignant human gliomas.
Bigner SH; Bjerkvig R; Laerum OD
Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489
[TBL] [Abstract][Full Text] [Related]
19. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY
J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
[TBL] [Abstract][Full Text] [Related]
20. The cytogenetic relationship between primary and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse.
Espinosa AB; Tabernero MD; Maíllo A; Sayagués JM; Ciudad J; Merino M; Alguero MC; Lubombo AM; Sousa P; Santos-Briz A; Orfao A
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):772-80. PubMed ID: 16467088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
